The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had (Q82132610)
Jump to navigation
Jump to search
scientific article published on 01 January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had |
scientific article published on 01 January 2006 |
Statements
The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment (English)
Stanley B Cohen
Ferdinand C Breedveld
Michael H Weisman
Arthur F Kavanaugh
Ronald van Vollenhoven
John Sharp
John L Perez
George T Spencer-Green